{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:42:04Z","timestamp":1790869324216,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.jgyn.2007.09.008","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T13:58:07Z","timestamp":1202306287000},"page":"5-15","source":"Crossref","is-referenced-by-count":18,"title":["\u00c9tat des connaissances\u00a0: prise en charge th\u00e9rapeutique de la pr\u00e9\u00e9clampsie"],"prefix":"10.1016","volume":"37","author":[{"given":"N.","family":"Winer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Tsasaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2007.09.008_bib1","first-page":"121","article-title":"R\u00e9animation des formes graves de pr\u00e9-\u00e9clampsie\u00a0: conf\u00e9rence d\u2019experts, Soci\u00e9t\u00e9 fran\u00e7aise d\u2019anesth\u00e9sie et de r\u00e9animation, Soci\u00e9t\u00e9 fran\u00e7aise de m\u00e9decine p\u00e9rinatale, Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie, Coll\u00e8ge national des gyn\u00e9cologues obst\u00e9triciens fran\u00e7ais","volume":"30","author":"Pottecher","year":"2001","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.jgyn.2007.09.008_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ajog.2006.11.002","article-title":"Identification of patients at risk for early onset and\/or severe preeclampsia with the use of uterine artery doppler velocimetry and placental growth factor","volume":"196","author":"Espinoza","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0029-7844(00)01223-0","article-title":"Pregnancy-related mortality from preeclampsia and eclampsia","volume":"97","author":"MacKay","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib4","first-page":"91","article-title":"The maternal mortality collaborative. Maternal mortality in the US: report from the the maternal collaborative","volume":"72","author":"Rochat","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib5","unstructured":"Preeclampsia foundation: www.preeclampsia.org."},{"key":"10.1016\/j.jgyn.2007.09.008_bib6","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","article-title":"Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)","volume":"169","author":"Sibai","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ajog.2007.02.021","article-title":"Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications","volume":"196","author":"Sibai","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005939","article-title":"Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure","volume":"19","author":"Meher","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2007.09.008_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0163-7258(97)82005-0","article-title":"Drug management of hypertensive disorders of pregnancy","volume":"74","author":"Khedun","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jgyn.2007.09.008_bib10","article-title":"Prise en charge de la pr\u00e9\u00e9clampsie EMC (elsevier SAS Paris)","author":"Haddad","year":"2006","journal-title":"Gynecologie-Obst\u00e9trique"},{"key":"10.1016\/j.jgyn.2007.09.008_bib11","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2007.09.008_bib12","first-page":"1559","article-title":"Prevention de la pr\u00e9\u00e9clampsie","volume":"32","author":"Desvaux","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.jgyn.2007.09.008_bib13","doi-asserted-by":"crossref","unstructured":"National high blood pressure education program working group on high blood pressure in pregnancy Report. Am J Obstet Gynecol 2000; 183: Suppl: S1\u2013S22.","DOI":"10.1067\/mob.2000.107928"},{"key":"10.1016\/j.jgyn.2007.09.008_bib14","first-page":"829","article-title":"Community-based home-care program for the management of pre-eclampsia: an alternative","volume":"149","author":"Helewa","year":"1993","journal-title":"CMAJ"},{"key":"10.1016\/j.jgyn.2007.09.008_bib15","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1177\/106002809402801208","article-title":"Use of nifedipine in the hypertensive diseases of pregnancy","volume":"28","author":"Levin","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jgyn.2007.09.008_bib16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1067\/mob.2002.126294","article-title":"Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy","volume":"187","author":"Brown","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)08049-0","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis","volume":"355","author":"von Dadelszen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2007.09.008_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01908159","article-title":"Calcium antagonists: definition and mode of action","volume":"76","author":"Nayler","year":"1981","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1471-0528.1993.tb15120.x","article-title":"Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33\u00a0weeks","volume":"100","author":"Impey","year":"1993","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/PRG-120028291","article-title":"Do commonly used oral antihypertensives alter fetal or neonatal heart rate characteristics? A systematic review","volume":"23","author":"Waterman","year":"2004","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.jgyn.2007.09.008_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1447-0756.1996.tb00930.x","article-title":"Sublingual nifedipine compared with intravenous hydralazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice","volume":"22","author":"Jegasothy","year":"1996","journal-title":"J Obstet Gynecol Res"},{"key":"10.1016\/j.jgyn.2007.09.008_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1471-0528.2000.tb13222.x","article-title":"Nifedipine in pregnancy","volume":"107","author":"Smith","year":"2000","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib23","first-page":"908","article-title":"Nicardipine treatment of hypertension during pregnancy","volume":"81","author":"Carbonne","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib24","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1097\/01.hjh.0000188729.73807.16","article-title":"Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients","volume":"23","author":"Hanff","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jgyn.2007.09.008_bib25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s001340050100","article-title":"Intravenous nicardipine for severe hypertension in pre-eclampsia \u2013 effects of an acute treatment on mother and foetus","volume":"25","author":"Aya","year":"1999","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgyn.2007.09.008_bib26","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-9378(99)70314-5","article-title":"A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy","volume":"181","author":"Vermillion","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib27","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/j.1552-4604.1993.tb01933.x","article-title":"Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis","volume":"33","author":"Saotome","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJMoa021180","article-title":"A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia","volume":"348","author":"Belfort","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2007.09.008_bib29","doi-asserted-by":"crossref","unstructured":"Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2006;3:CD001449.","DOI":"10.1002\/14651858.CD001449.pub2"},{"key":"10.1016\/j.jgyn.2007.09.008_bib30","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/0002-9378(95)91412-9","article-title":"Neonatal outcome after preterm delivery for preeclampsia","volume":"172","author":"Friedman","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9378(95)90222-8","article-title":"Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994","volume":"173","author":"Crowley","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9378(00)70513-8","article-title":"Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford network","volume":"182","author":"Bernstein","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.semperi.2006.01.008","article-title":"Preeclampsia as a cause of preterm and late preterm (near-term) births","volume":"30","author":"Sibai","year":"2006","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib34","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0002-9378(99)70630-7","article-title":"Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia","volume":"180","author":"Amorim","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib35","first-page":"1070","article-title":"Aggressive or expectant management for patients with severe preeclampsia between 28 and 34 weeks\u2019 gestation: a randomized controlled trial","volume":"76","author":"Odendaal","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9378(94)90104-X","article-title":"Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks\u2019 gestation: a randomized controlled trial","volume":"171","author":"Sibai","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib37","first-page":"626","article-title":"Conservative management of severe preeclampsia remote from term","volume":"84","author":"Schiff","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib38","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1067\/mob.2000.107334","article-title":"A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis","volume":"182","author":"Terrone","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib39","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/01.AOG.0000236445.18265.93","article-title":"Magnesium sulfate tocolysis: time to quit","volume":"108","author":"Grimes","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib40","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2007.09.008_bib41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.AOG.0000152351.13671.99","article-title":"Diagnosis, prevention, and management of eclampsia","volume":"105","author":"Sibai","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/3-211-32318-X_23","article-title":"Magnesium sulfate for brain protection during temporary cerebral artery occlusion","volume":"95","author":"Chan","year":"2005","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.jgyn.2007.09.008_bib43","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9378(99)70279-6","article-title":"Pretreatment with magnesium sulfate protects against hypoxic-ischemic brain injury but postasphyxial treatment worsens brain damage in seven-day-old rats","volume":"180","author":"Sameshima","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib44","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0002-9378(90)90002-O","article-title":"Magnesium sulfate is the ideal anticonvulsant in pr\u00e9\u00e9clampsie\u2013eclampsia","volume":"162","author":"Sibai","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0270-9295(04)00132-9","article-title":"Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials","volume":"24","author":"Villar","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib46","doi-asserted-by":"crossref","unstructured":"The eclampsia collaborative group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 1995; 345:1455\u201363.","DOI":"10.1016\/S0140-6736(95)91034-4"},{"key":"10.1016\/j.jgyn.2007.09.008_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJM199507273330401","article-title":"A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia","volume":"333","author":"Lucas","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2007.09.008_bib48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9378(97)70558-1","article-title":"The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial","volume":"176","author":"Witlin","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1081\/PRG-120015845","article-title":"Labetalol decreases cerebral perfusion pressure without negatively affecting cerebral blood flow in hypertensive gravidas","volume":"21","author":"Belfort","year":"2002","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.jgyn.2007.09.008_bib50","first-page":"145","article-title":"Cardio-pulmonary arrest after the administration of magnesium sulfate","volume":"67","author":"Richards","year":"1985","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jgyn.2007.09.008_bib51","doi-asserted-by":"crossref","unstructured":"The Magpie trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. Magpie trial follow-up study collaborative group. BJOG. 2007; 114:300\u20139.","DOI":"10.1111\/j.1471-0528.2006.01166.x"},{"key":"10.1016\/j.jgyn.2007.09.008_bib52","unstructured":"ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002; 99: 159\u201367."},{"key":"10.1016\/j.jgyn.2007.09.008_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gyobfe.2005.06.025","article-title":"Inter\u00eat du sulfate de magnesium dans la prise en charge de la pr\u00e9\u00e9clampsie","volume":"34","author":"Rozenberg","year":"2006","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jgyn.2007.09.008_bib54","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0002-9378(85)80222-2","article-title":"Hemodynamic observations in severe preeclampsia complicated by pulmonary edema","volume":"152","author":"Benedetti","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib55","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1471-0528.1991.tb15333.x","article-title":"Respiratory function in severe gestational proteinuric hypertension: the effects of rapid volume expansion and subsequent vasodilatation with verapamil","volume":"98","author":"Belfort","year":"1991","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib56","first-page":"1377","article-title":"The rate of maternal complications in 107 pregnancies complicated with HELLP syndrome","volume":"147","author":"Hupuczi","year":"2006","journal-title":"Orv Hetil"},{"key":"10.1016\/j.jgyn.2007.09.008_bib57","first-page":"367","article-title":"Role of volume expansion in severe pre-eclampsia","volume":"167","author":"Kirshon","year":"1988","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2007.09.008_bib58","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-0528.2005.00687.x","article-title":"PETRA investigators. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia","volume":"112","author":"Ganzevoort","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2007.09.008_bib59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1471-0528.1995.tb09062.x","article-title":"Temporising management of severe pre-eclampsia with and without the HELLP syndrome","volume":"102","author":"Visser","year":"1995","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib60","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1471-0528.2005.00614.x","article-title":"Morbidity and development in childhood of infants born after temporising treatment of early onset pre-eclampsia","volume":"112","author":"Withagen","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2007.09.008_bib61","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"329","author":"Sibai","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2007.09.008_bib62","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ajog.2004.03.050","article-title":"Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks\u2019 gestation","volume":"190","author":"Haddad","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib63","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2007.09.008_bib64","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0002-9378(87)80300-9","article-title":"Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole","volume":"157","author":"Wallenburg","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib65","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9378(88)80034-6","article-title":"Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency","volume":"159","author":"Trudinger","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198908103210604","article-title":"Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension","volume":"321","author":"Benigni","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2007.09.008_bib67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jama.1991.03470020086038","article-title":"A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease","volume":"266","author":"Imperiale","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jgyn.2007.09.008_bib68","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0140-6736(91)93124-R","article-title":"Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial","volume":"337","author":"Uzan","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2007.09.008_bib69","doi-asserted-by":"crossref","unstructured":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative low-dose aspirin study in pregnancy) collaborative group. Lancet. 1994; 343:619\u201329.","DOI":"10.1016\/S0140-6736(94)92633-6"},{"key":"10.1016\/j.jgyn.2007.09.008_bib70","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2007.09.008_bib71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","article-title":"A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica low dose aspirin study group","volume":"105","author":"Golding","year":"1998","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib72","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","article-title":"Barbados low dose aspirin study in pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications","volume":"105","author":"Rotchell","year":"1998","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib73","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100mg) used for prevention of preeclampsia in nulliparous women: The essai regional aspirin mere enfant study (part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib74","unstructured":"Knight M, Duley L, Henderson-Smart D, King J. Antiplatelet agents for preventing and treating pre-eclampsia. In: Cochrane Collaboration: Cochrane Library. Issue 3. Oxford: Update Software, 2000."},{"key":"10.1016\/j.jgyn.2007.09.008_bib75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","article-title":"Antiplatelet drugs for prevention of preeclampsia and its consequences: systematic review","volume":"322","author":"Duley","year":"2001","journal-title":"Br Med J"},{"key":"10.1016\/j.jgyn.2007.09.008_bib76","doi-asserted-by":"crossref","unstructured":"L Duley, DJ Henderson-Smart, M Knight, JF King Antiplatelet agents for preventing pre-eclampsia and its complications Cochrane Database Syst Rev 2006 Issue.","DOI":"10.1002\/14651858.CD004659.pub2"},{"key":"10.1016\/j.jgyn.2007.09.008_bib77","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"PARIS collaborative group antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2007.09.008_bib78","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1056\/NEJM198703193161204","article-title":"Hypocalciuria in preeclampsia","volume":"316","author":"Taufield","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2007.09.008_bib79","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jama.1983.03330330039033","article-title":"Reduction of blood pressure with calcium supplementation in young adults","volume":"249","author":"Belizan","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.jgyn.2007.09.008_bib80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199707103370201","article-title":"Trial of calcium to prevent preeclampsia","volume":"337","author":"Levine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2007.09.008_bib81","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ajog.2006.01.068","article-title":"World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women","volume":"194","author":"Villar","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001059.pub2","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems","volume":"3","author":"Hofmeyr","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2007.09.008_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1651-2227.2001.tb01619.x","article-title":"Is oxidative stress involved in the aetiology of pre-eclampsia?","volume":"90","author":"Poston","year":"2001","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.jgyn.2007.09.008_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09513590500097382","article-title":"Potential atherogenic roles of lipids, lipoprotein A and lipid peroxidation in preeclampsia","volume":"21","author":"Bayhan","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib85","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)80010-5","article-title":"Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial","volume":"354","author":"Chappell","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2007.09.008_bib86","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa054186","article-title":"Vitamins C and E and the risks of preeclampsia and perinatal complications","volume":"354","author":"Rumbold","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2007.09.008_bib87","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(06)68433-X","article-title":"Vitamins in pre-eclampsia (VIP) trial consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial","volume":"367","author":"Poston","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2007.09.008_bib88","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.gco.0000247393.86968.e6","article-title":"New therapies in the prevention of preeclampsia","volume":"18","author":"Spinnato","year":"2006","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2007.09.008_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003402.pub2","article-title":"Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction","volume":"3","author":"Makrides","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2007.09.008_bib90","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.rdc.2006.05.007","article-title":"Management of antiphospholipid syndrome in pregnancy","volume":"32","author":"Petri","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jgyn.2007.09.008_bib91","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10641950109152640","article-title":"Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias","volume":"20","author":"Kupferminc","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.jgyn.2007.09.008_bib92","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.HYP.0000149950.05182.a3","article-title":"Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women","volume":"45","author":"Mello","year":"2005","journal-title":"Hypertension"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231507003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231507003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T23:57:58Z","timestamp":1708559878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231507003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0368231507003808"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2007.09.008","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}